Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Infect Dis Ther. 2021 Sep;10(3):1807-1809. doi: 10.1007/s40121-021-00443-5. Epub 2021 Apr 29.

Authors

Rajesh Naidu Janapala¹, Jigar Patel², Omar Belfaqeeh², Abdulla Alhashmi², Ali Pourmand²

Affiliations

¹ International Medicine Program, George Washington University School of Medicine and Health Sciences, 2120 L St., Washington, DC, 20037, USA. Rajeshnaidu.md@gmail.com.
² International Medicine Program, George Washington University School of Medicine and Health Sciences, 2120 L St., Washington, DC, 20037, USA.

No abstract available

Keywords: COVID-19; Mortality benefit; Steroids; Tocilizumab.

Publication types

Letter